Articles

Page 7 of 9

Exploring the Impact of health-care cost sharing mechanisms in health service users for all the 27 member countries of the EU

Authors: Andreas Siakou and Costas Athanasakis

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P29

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines

Authors: Maarten Van Baelen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P28

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Medicines optimisation in Northern Ireland - scope and results of a challenging project

Authors: Mike Scott, Frans van Andel and Rob Brenninkmeijer

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P27

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The effective and innovative cost saving of software in managing unregistered drugs

Authors: Nur Wahida Zulkifli, Noorizan Abd Aziz, Yahaya Hassan, Mohamed Azmi Hassali and Nur Liyana Zainal Bahrin

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P25

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Pharmaceutical distribution remuneration in Europe

Authors: Sabine Vogler, Lena Lepuschütz and Peter Schneider

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P23

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Reimbursement measures in European countries – findings of a bibliometric literature review

Authors: Sabine Vogler, Nina Zimmermann, Antonio Olry de Labry and Jaime Espin

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P21

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The prices outpatients have to pay for purchasing medicines in Armenia

Authors: Irina Kazaryan, Anahit Sevikyan and Margarit Melikyan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P20

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Access of high technology medicines in Russia

Authors: Liudmila Bezmelnitsyna, Dmitry Meshkov and Ramil Khabriev

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P19

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Optimising prescribing in primary care: an evaluation of financial and clinical parameters

Authors: Asal Albayati, David Lu, Liam Sergeant, Nandita Singh, Keith Crump and Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P18

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Authors: Rossen M Kazakov and Penka I Petrova

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P17

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Prices of oncology medicines in European countries, Australia and New Zealand

Authors: Sabine Vogler, Agnes Vitry and Zaheer Ud-Bin-Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P16

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Collaborative models for increasing efficiency of early drug assessment

Authors: Anna Nachtnebel and Claudia Wild

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O15

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Value of generic medicines: an health economics study

Authors: Martin Albrecht, Ariane Höer and Anne Zimmermann

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P15

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience

Authors: Nur Liyana Zainal Bahrin, Yahaya Hassan, Abu Bakar Abd Majeed, Nur Wahida Zulkifli and Azlan Ahmad

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P14

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir

Authors: Hedi Schelleman, Rudy Dupree, Finn B Kristensen and Wim Goettsch

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O13

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

Authors: Christine Leopold, James D Chambers and Anita K Wagner

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P13

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities

Authors: Sabine Vogler, August Österle and Susanne Mayer

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O12

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets

Authors: Kristina Hristova and Claudia Habl

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P12

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

Authors: Yared Santa-Ana-Tellez, Veronika J Wirtz, Hubert GM Leufkens and Aukje K Mantel-Teeuwisse

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O11

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Determining the prices of the medicines in the absence of superiority over alternative medical technology

Authors: Wojciech Matusewicz, Katarzyna Jagodzińska-Kalinowska, Aneta Lipińska and Maciej Pomorski

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P11

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors

Authors: Susan Spillane, Cara Usher, Kathleen Bennett, Roisin Adams and Michael Barry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O10

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Availability and affordability of medicines for children

Authors: Irina Kazaryan and Lusine Vardanyan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P10

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results

Authors: Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri and Daniela Roggeri

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P9

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Approval, reimbursement and pricing of high-cost cancer medicines in Australia

Authors: Agnes Vitry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O9

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Policy options to deal with high-cost medicines – survey with European policy-makers

Authors: Nina Zimmermann, Sabine Vogler and Hanne Bak Pedersen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P8

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer

Authors: Aris Angelis and Panos Kanavos

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O8

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Developing a Drug Price Reference Index in the Philippines

Authors: Manuel A Haasis, Anna M Guerrero and Marinette J Ladioray

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P7

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework

Authors: Panos Kanavos and Aris Angelis

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O7

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Retrospective financial analysis of medicines reimbursement services in community pharmacy

Authors: Elena Chitan

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P6

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences

Authors: Zaheer-Ud-Din Babar, Abdul Ali, Christine Kim, James Mcintosh, Malaika Samuel Namdas, Erica Lourdes Rodrigues, Komal Vallabh and Anne Rew

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O6

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Pharmaceutical policies in Australia and New Zealand

Authors: Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K5

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system

Authors: Dumebi O Mordi, Kwesi Eghan and Jim Rankin

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P5

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?

Authors: Sabine Vogler, Nina Zimmermann and Kees De Joncheere

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E4

Content type: Commentary

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of delisting OTC medicines from reimbursement list

Authors: Petra Chytilová and Robin Šebesta

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P4

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of discounts on medicine prices

Authors: Peter Schneider and Sabine Vogler

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O4

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Policy cooperation and interface issues

Authors: Sabine Vogler, Nina Zimmermann, Veronika J Wirtz and Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E3

Content type: Editorial

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Pharmaceutical pricing and reimbursement policies: perspectives for the future

Authors: Andrew L Gray

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K3

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region

Authors: Tuan A Nguyen, Sun Qiang, Haipeng Wang, Krishna Undela and Agnes Vitry

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P3

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Managing new premium-priced medicines in Europe

Authors: Govin Permanand and Hanne Bak Pedersen

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K2

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Policies beyond the crisis: lesson learned

Authors: Sabine Vogler, Nina Zimmermann, Veronika J Wirtz and Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E2

Content type: Editorial

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Authors: Jaana E Martikainen, Timo Maljanen, Hanna Koskinen and Sabine Vogler

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P2

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs

Authors: Elizabeth Docteur and Ruth Lopert

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O2

Content type: Oral presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Challenges and opportunities for pharmaceutical pricing and reimbursement policies

Authors: Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J Wirtz and Zaheer-Ud-Din Babar

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E1

Content type: Editorial

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Affordable innovation: future directions in pharmaceutical policy

Authors: Suzanne R Hill

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K1

Content type: Keynote speaker presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin

Authors: Jessica Fraeyman, Hans De Loof, Guido Van Hal, Guido De Meyer, Roy Remmen and Philippe Beutels

Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P1

Content type: Poster presentation

Published on: 5 October 2015

This article is part of a Supplement: Volume 8 Supplement 1
- View Full Text
- View PDF
Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study

Retail drug sellers are a major source of health care and medicines in many countries. In Tanzania, drug shops are widely used, particularly in rural and underserved areas. Previously, the shops were allowed t...

Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:23

Content type: Policy analysis

Published on: 25 September 2015

The Erratum to this article has been published in Journal of Pharmaceutical Policy and Practice 2015 8:29
- View Full Text
- View PDF
Policy versus practice: a community-based qualitative study of the realities of pharmacy services in Nunavut, Canada

Nunavut is an Arctic territory in Canada subject to many social, economic and health disparities in comparison to the rest of the nation. The territory is affected by health care provision challenges caused by...

Authors: Sandra J. Romain, Jillian C. Kohler and Kue Young

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:22

Content type: Research

Published on: 21 September 2015
- View Full Text
- View PDF
Access to and quality use of non-communicable diseases medicines in Nepal

Noncommunicable diseases are a major healthcare problem in Nepal and their burden is increasingevery year. Noncommunicable diseases (NCDs) bring additional challenges to the Nepalese healthcaresystem which is ...

Authors: Bhuvan K.C., Susan Heydon and Pauline Norris

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:21

Content type: Commentary

Published on: 31 August 2015
- View Full Text
- View PDF
Parents’ preferences and willingness-to-pay for human papilloma virus vaccines in Thailand

To examine parents’ preferences and willingness-to-pay (WTP) for HPV vaccines.

Authors: Surachat Ngorsuraches, Kornwan Nawanukool, Krittin Petcharamanee and Ungkanit Poopantrakool

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:20

Content type: Research article

Published on: 22 July 2015
- View Full Text
- View PDF
Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

In 2007, the Sixtieth World Health Assembly (WHA) passed a resolution entitled “Better medicines for children” and subsequently the World Health Organization (WHO) recommended the inclusion of child-appropriat...

Authors: Xavier Nsabagasani, Ebba Hansen, Anthony Mbonye, Freddie Ssengooba, Herbert Muyinda, James Mugisha and Jasper Ogwal-Okeng

Citation: Journal of Pharmaceutical Policy and Practice 2015 8:19

Content type: Research article

Published on: 15 July 2015
- View Full Text
- View PDF

Articles

Official journal of

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

Contact us